Hepatitis C Death Cases Will Diminish Out of England with Pioneering Drug Deal Including Patients with Liver Disease and Cancer

Medicine & Technology Dec 28, 2022

The UK Health sector proposes that hepatitis C death cases will diminish with a pioneering drug deal that may also aid liver and cancer patients. Read on to know more about this news here!

Nobel Prize Awarded to the Three Scientists Who Discovered Hepatitis C

Oct 05, 2020

A Nobel Prize was awarded to three scientists who were credited with the discovery of the Hepatitis C virus, announced Monday, September 5.

Patients Receiving Hepatitis C Positive Liver Transplants Become Cleared of the Virus

Jun 23, 2020

A new liver allograft trial resulted in patients being cleared of hepatitis C after receiving an infected liver from donors.

Researchers Analyze How Immune Responses to Hepatitis C Applied to SARS-CoV-2

Jun 17, 2020

Scientists believe that a genetic analysis of the immune system's defense mechanism against hepatitis C can be used for coronavirus vaccine development.

Experts In Boston Saved 66 Patients With Hepatitis C Virus: Here’s How Doctors Attained Success

May 10, 2017

Another feat in the field of medicine was plotted as experts in Boston were able to successfully treated 66 patients affected with the fatal Hepatitis C virus.

How To Approach Hepatitis C-diagnosed People With Substance Abuse

Apr 27, 2017

In an editorial, a doctor in University of Buffalo has said that people with Hepatitis C and substance use disorder are having a hard accessing to proper healthcare.

Researchers Discover Specific IFNL Protein Responsible For Liver Disease

Apr 25, 2017

Researchers have recently discovered specific IFNL protein that plays the key role in forming the crucial liver disease.

Hepatitis B, C Will Be Gone By 2030 In The U.S.

Mar 30, 2017

Hepatitis B and C can be completely gone and lost in 2030 in the U.S. if the federal government wants it.

Link Between Hepatitis C and Parkinson’s Disease -- Study

Jan 11, 2016

Parkinson’s disease and hepatitis are different types of diseases. However, a link between the two has been found by the latest study.

Hepatitis C On the Rise in Appalachia

May 08, 2015

The rates of hepatitis C infections have more than tripled in four Appalachian states from 2006 to 2012, fueled by prescription drug abuse among those who inject drugs, especially in rural areas, United States health officials said.

India's Patent Office Breaths New Life On The Production Of Hepatitis C Medication, Gilead Shot-Down In The Process

Jan 21, 2015

Hepatitis C is a life-or-death disease of the liver that's known to be prevalent in third-world countries. But, with a steep medication price, treatment is often times a luxury. But with new Indian-based pharmaceutical companies joining Gilead, that all may change in the near future.

Hep-C Treatment On a Budget - Why Prices are Plummeting

Dec 23, 2014

After months of waiting and anticipation, the hepatitis C treatment price wars are finally getting under way. Express Scripts, the largest pharmacy benefits manager in the U.S., has released a new treatment from AbbVie as its exclusive treatment for patients with genotype 1, the most common form of the chronic disease. This drug covers 75% of the estimated 3.2 million Americans who are infected. And this new drug will likely change the market for the hepatitis C treatments that are currently led by a pair of medications from Gilead Sciences which is likely to reach $20 billion in revenue next year thanks to demand for its treatments.